Agile Therapeutics, Inc. (AGRX) Social Stream
AGILE THERAPEUTICS INC (AGRX) Price Targets From Analysts
Use the tables below to see what analysts covering AGILE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 5 | $5 | $2.5 | $3.875 | $2.02 | 91.83% |
| 2021-11-26 | 5 | $5 | $2 | $3.375 | $2.02 | 67.08% |
| 2022-01-20 | 4 | $5 | $2 | $3.375 | $2.02 | 67.08% |
| 2022-03-31 | 3 | $5 | $1.5 | $2.75 | $2.02 | 36.14% |
| 2022-07-11 | 2 | $80 | $5 | $42.5 | $2.02 | 2003.96% |
| 2022-08-19 | 2 | $5 | $1 | $3 | $2.02 | 48.51% |
| 2022-12-30 | 2 | $3 | $1 | $2 | $2.02 | -0.99% |
| 2023-06-26 | 2 | $12 | $12 | $12 | $2.02 | 494.06% |
The Trend in the Analyst Price Target
AGRX's average price target has moved up $4.8 over the prior 37 months.
Over the past 178 days, AGRX's average upside potential has been 22,255.77%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-30 | 2 | 150 | 150 | 150 | 0.227 | 65979.3% |
| 2022-12-30 | 2 | 150 | 50 | 100 | 0.227 | 43952.86% |
| 2022-12-30 | 2 | 3 | 1 | 2 | 0.227 | 781.06% |
| 2023-06-07 | 2 | 12 | 12 | 12 | 3.680 | 226.09% |
| 2023-06-26 | 2 | 12 | 12 | 12 | 2.730 | 339.56% |
AGRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
AGRX's average broker recommendation rating worsened by 0.67 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AGRX as an investment opportunity.
- AGILE THERAPEUTICS INC's number of analysts covering the stock is higher than 102.73% of all US stocks.
- In the context of all US stocks, AGILE THERAPEUTICS INC's variance in analysts' estimates is lower than -866.12% of them.
- In terms of how AGILE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 461.24% of that group.
- In the context of stocks in the micro market cap category, AGILE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 698.06% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AGILE THERAPEUTICS INC are PHIO, ORGS, and EVOK.
View All Top Stocks by Price Target
Make investment decisions regarding AGRX using the data that counts. Try POWR Ratings for free.